For most medications, a father's use does not create the same birth-defect risk as maternal use during pregnancy. The father does not share a blood supply with the fetus, and drug amounts in semen are usually too small to cause fetal exposure. The bigger paternal question is often whether a medication affects sperm production, hormones, sexual function, or genetic integrity.
Do not copy the mother's medication rules onto the father
Why paternal medication exposure is different
A person taking a medication during pregnancy can expose the embryo or fetus through the bloodstream and placenta.
A father or sperm donor does not share a blood supply with the pregnancy. MotherToBaby notes that although tiny amounts of some substances may enter semen, for most exposures intercourse is not expected to increase birth-defect risk.
The bigger issue may be fertility rather than fetal exposure
Some medications can affect:
- sperm production
- sperm count or motility
- testosterone and reproductive hormones
- libido
- erection or ejaculation
That can make conception harder even when the medication is not considered a fetal exposure hazard through semen.
Testosterone is the classic example
Exogenous testosterone can suppress the hormonal signals that drive sperm production. A man can have normal or high blood testosterone while sperm production falls dramatically.
AUA/ASRM male-infertility guidance specifically advises that testosterone monotherapy should not be prescribed to men interested in current or future fertility.
Chemotherapy and radiation are different again
Cancer treatments can damage sperm production temporarily or permanently. Fertility preservation before treatment can therefore be time-sensitive.
For some treatments, clinicians also recommend avoiding conception for a defined period because of potential effects on sperm or because the medication itself has specific reproductive warnings.
That timing must be drug-specific.
What about common chronic-disease medicines?
Many medications used for autoimmune disease, hypertension, depression, inflammatory bowel disease, or other chronic conditions do not create meaningful paternal pregnancy risk simply because the drug has warnings for pregnant patients.
Do not assume the pregnancy section of a medication leaflet applies identically to the father.
What should a man bring to the preconception visit?
- Prescriptions and doses.
- Testosterone, anabolic steroids, or performance-enhancing drugs.
- Finasteride/dutasteride or other hair-loss treatments.
- Supplements and recreational substances.
- Recent chemotherapy or radiation.
- Any drug started around the same time fertility or sexual function changed.
When is a reproductive urologist useful?
If there is an abnormal semen analysis, azoospermia, severe oligospermia, exogenous testosterone use, prior chemotherapy/radiation, testicular disease, or another clear male-factor concern, a reproductive-urology evaluation can identify whether medication is part of the problem.
Frequently asked questions
Can a father's medication cause birth defects through semen?
For most paternal medication exposures, drug levels in semen are too low to be expected to increase birth-defect risk. Specific drugs can have special guidance.
Can testosterone reduce sperm count?
Yes. Exogenous testosterone can suppress the hormones required for sperm production and can cause very low counts or azoospermia.
Should men stop all medications before TTC?
No. Review specific medications with the prescriber or reproductive specialist rather than stopping necessary treatment indiscriminately.
